RAD51 135G>C polymorphism and risk of sporadic colorectal cancer in Iranian population

被引:8
|
作者
Yazdanpanahi, Nasrin [1 ]
Salehi, Rasoul [2 ]
Kamali, Sara [2 ]
机构
[1] Islamic Azad Univ, Falavarjan Branch, Dept Genet, Esfahan, Iran
[2] Isfahan Univ Med Sci, Sch Med, Dept Genet & Mol Biol, Esfahan, Iran
关键词
Iran; RAD51 135G>C polymorphism; sporadic colorectal cancer; SINGLE NUCLEOTIDE POLYMORPHISM; DOUBLE-STRAND BREAKS; GENE; PROTEIN; REPAIR; INSTABILITY; CARRIERS;
D O I
10.4103/0973-1482.183558
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Aim of Study: Colorectal cancer (CRC) is among the most common cancers and accounts as the second leading cause of death from cancers in the world. RAD51 plays a crucial role in double-strand breaks repair of DNA. Single nucleotide polymorphisms within this gene could influence on the potential of DNA repair and in consequence on the susceptibility to various tumors such as CRC. This is the first report about the role of RAD51 polymorphisms in Iranian CRC susceptibility. The study was conducted to evaluate the association of 135G>C polymorphism of RAD51 gene with sporadic CRC in a subset of Iranian population. Materials and Methods: The current case-control study was performed from 2013 to 2015. One hundred patients with sporadic CRC and one hundred controls were enrolled from two referral centers in Isfahan. All samples were genotyped for the RAD51 gene using polymerase chain reaction-restriction fragment length polymorphism assay. Results: The results revealed no significant association between the RAD51 135G>C and sporadic CRC (odds ratio = 0.86, 95% confidence interval = 0.464-1.595). The frequency of genotypes and also alleles of the mentioned polymorphism were not significantly different between case and control groups (P = 0.2 and 0.4, respectively). Conclusion: The results suggest that RAD51 135G> C probably has not a crucial role in Iranian CRC risk and is not an important potential risk factor in molecular diagnostics of mentioned disease among Iranian population.
引用
收藏
页码:614 / 618
页数:5
相关论文
共 50 条
  • [21] New conflicting results obtained in the subgroup analysis of RAD51 135G>C polymorphism and breast cancer risk
    Pei-Hua Lu
    Min-Bin Chen
    Wei Shen
    Chen Li
    Ming-Yu Wu
    Guo-Qing Tao
    Breast Cancer Research and Treatment, 2011, 126 : 265 - 266
  • [22] RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies
    Gao, Lin-Bo
    Pan, Xin-Min
    Li, Li-Juan
    Liang, Wei-Bo
    Zhu, Yi
    Zhang, Lu-Shun
    Wei, Yong-Gang
    Tang, Ming
    Zhang, Lin
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) : 827 - 835
  • [23] Positive effect of single nucleotide RAD51 135G>C polymorphism and low Ku70 protein expression on female rectal cancer patients survival after preoperative radiotherapy
    Gasinska, Anna
    Biesaga, Beata
    Widla, Anna Janecka
    Darasz, Zbigniew
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30 (01): : 3 - 14
  • [24] Genetic polymorphism of RAD51 influences susceptibility to colorectal cancer in Chinese population
    Zhong, J.
    Liu, S. -Q
    Tang, J. -C
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (11) : 4865 - 4875
  • [25] The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer
    K. Söderlund Leifler
    A. Asklid
    T. Fornander
    M. Stenmark Askmalm
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 797 - 804
  • [26] Examination of RAD51 gene G135C polymorphism in gastric cancer patients in northeastern Anatolia
    Gok, Ilhami
    Ozden, Ozkan
    ARCHIVES OF BIOLOGICAL SCIENCES, 2019, 71 (02) : 209 - 213
  • [27] RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies
    Yu, Ke-Da
    Yang, Chen
    Fan, Lei
    Chen, Ao-Xiang
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (02) : 365 - 371
  • [28] RAD51 135G>C Does Not Modify Breast Cancer Risk in Non-BRCA1/2 Mutation Carriers: Evidence from a Meta-Analysis of 12 Studies
    Yu, K-D
    Shao, Z-M.
    CANCER RESEARCH, 2010, 70
  • [29] 135G/C polymorphism in the RAD51 gene and acute myeloid leukemia risk: a meta-analysis
    Wu, L.
    Long, Z. G.
    Dai, Z. S.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02)
  • [30] Polymorphism RAD51 172G > T in Serbian patients with colorectal cancer
    Petrovic-Sunderic, Jelena
    Dragicevic, Sandra
    Krnjajic, Mina
    Ristanovic, Momcilo
    Nikolic, Aleksandra
    Krivokapic, Zoran
    JOURNAL OF BUON, 2018, 23 (04): : 936 - 940